Home

English
Afrikaans

CONTACT US
+27 21 888 3000
info@remgro.com

MENUMENU

About
Remgro
Investor
Centre
- - - Mediclinic Results
    - Events
Group
Investments
ESG and
sustainability
Media
Centre
- - - Media releases
    - Circulars
  - - Media contact
    - Logo Library

Remgro CMD Mediclinic Investment thesis FINAL 140425

Posted 10:31 am by remgrowp_GKfsl9 & filed under .

LATEST NEWS

Remgro Capital Markets Day 2025
Interim report – unaudited results for the six months ended 31 December 2024
Interim results presentation

PLAYBACK

Webcast: themediaframe.com/links/remgro250325.html

SENS RELEASES

LATEST NEWS

- - Report on proceedings at the AGM
    - SENS announcement
    - Approved targets – Remuneration Policy 2024

TCFD Report
2024

ESG and Sustainability
Report 2024

Annual Financial
Statements 2024

Integrated Annual
Report 2024

Overview

Head Office
Millennia Park
16 Stellentia Avenue
Stellenbosch, 7600

+27 21 888 3000
info@remgro.com

CAREERS
GROUP SITES

ETHICS HOTLINE 0800 222 536

Invenfin is the venture and growth capital division of Remgro

VISIT THE SITE >

2025 © Remgro Limited

E-mail Disclaimer | Terms of Use | Privacy Policy | PAIA | Site Map

About
Remgro
▼
Investor
Centre
▼
Group
Investments
▼
ESG and
sustainability
▼
Media
Centre
▼